Hematopoietic Progenitor Cell Antigen CD34 (CD34) Antibody (Biotin)

Este producto es parte de CD34 - CD34 molecule
Hematopoietic Progenitor Cell Antigen CD34 (CD34) Antibody (Biotin)
364€ (0.1 mg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Hematopoietic Progenitor Cell Antigen CD34 (CD34) Antibody (Biotin)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx139251
Tested Applications
WB, IHC, IF/ICC, FCM

Description

CD34 Antibody is a Mouse Monoclonal against CD34.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Hematopoietic Progenitor Cell Antigen CD34 (CD34)
Immunogen: Permanent Human cell line derived from peripheral leucocytes of a patient suffering from chronic myeloid leukaemia.
Host
Mouse
Reactivity
Human
Assay Type
Concentration: 1 mg/ml
Recommended Dilution
Validated in IHC-P and ICC. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Biotin
Isotype
IgG1
Clone ID
E334
Size 1
0.1 mg
Tested Applications
WB, IHC, IF/ICC, FCM
Buffer
PBS solution with 15 mM sodium azide.
Availability
Shipped within 5-12 working days.
Storage
Store at 2-8°C. Do not freeze.
Dry Ice
No
UniProt ID
P28906
Gene ID
947
Alias
Hematopoietic progenitor cell antigen CD34
Background
Antibody anti-CD34
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

CD34 is a well-known cell surface glycoprotein that is primarily expressed on hematopoietic stem and progenitor cells (HSPCs), as well as on endothelial cells, and is used as a marker to identify early stem cells within the bone marrow and other tissues. This molecule has become an invaluable tool in both research and clinical medicine, particularly in the isolation and characterization of hematopoietic stem cells for bone marrow transplantation, and in the study of angiogenesis due to its presence on vascular endothelium. The CD34 protein belongs to the family of sialomucin-like adhesion molecules. Initially, it was identified as a marker on hematopoietic progenitor cells and subsequently found to be involved in various physiological processes, such as cell adhesion, cell signaling, and migration. CD34 is a highly glycosylated protein, and its extensive post-translational modifications, including sialylation and O-glycosylation, play important roles in its function, particularly in regulating cell-cell interactions and hematopoietic cell homing.